Search

Your search keyword '"Pileggi, Gecilmara"' showing total 222 results

Search Constraints

Start Over You searched for: Author "Pileggi, Gecilmara" Remove constraint Author: "Pileggi, Gecilmara"
222 results on '"Pileggi, Gecilmara"'

Search Results

1. Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study

2. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study

3. Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study

4. Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil

5. Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

6. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

7. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

8. COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months.

9. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data

10. Spotlight on latent tuberculosis infection screening for juvenile idiopathic arthritis in two countries, comparing high and low risk patients

12. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry

13. Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force

14. How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study

15. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil

16. Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination

19. Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America

20. Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study Safer

22. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study

23. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

24. Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of Chikungunya fever. Part 1 – Diagnosis and special situations

25. Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2 – Treatment

28. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases

29. How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.

31. Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey

32. DISEASE ACTIVITY OR LONG COVID-19 MANIFESTATIONS? DATA FROM THE REUMACOV BRASIL COHORT

33. INFLUENZA AND PNEUMOCOCCAL VACCINATION COVERAGE AMONG PATIENTS WITH JUVENILE IMMUNE-MEDIATED RHEUMATIC DISEASES: PRELIMINARY RESULTS OF A MULTICENTER CROSS- SECTIONAL STUDY

34. THE IMPACT OF COVID-19 IN PATIENTS WITH SYSTEMIC VASCULITIDES. DATA FROM REUMACOV BRAZIL REGISTER

35. COVID-19 VACCINATION IN CHILDREN WITH IMMUNE MEDIATED RHEUMATIC DISEASES: PRELIMINARY RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY

36. REACTOGENICITY OF IMMUNIZANTS AGAINST COVID-19 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A BRAZILIAN COORT

37. Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil

38. Comparison Of The Immunogenicity Among Covid-19 Vaccines Chadox1, Coronavac Or Bnt162b2 In Systemic Lupus Erythematosus (Sle): A Prospective Cohort

39. Safety assessment of BNT162b2, SinoVac and ChAdOx1 vaccines in Systemic Lupus Erythematosus patients – Data from SAFER Study

40. IMMUNOGENICITY AND SAFETY OF THE CHADOX-1 COVID-19 VACCINE IN PATIENTS WITH AUTOIMMUNE DISEASES AND HEALTHY CONTROLS: DATA FROM SAFER STUDY

41. 2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis

42. Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil.

43. Additional file 1 of Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force

44. Additional file 1 of Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry

45. Additional file 1 of COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data

46. ANALYSIS OF THE VACCINATION STATUS OF STUDENTS AT A MEDICAL SCHOOL.

47. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

48. Country-Level Factors Associated With COVID-19-Related Death in People With Rheumatic Disease: Results From the COVID-19 Global Rheumatology Alliance Registry

49. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry

50. Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases

Catalog

Books, media, physical & digital resources